person

Magalie M.

Country
France
Department
Pneumology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 40 partner sites.

Specializations

Pulmonary Oncology

Investigator concentrates on malignant respiratory diseases, notably diverse forms of non‑small cell lung cancer and related small‑cell lung cancer.

  • Targeted molecular therapies
  • Immune‑checkpoint inhibition
  • Neoadjuvant and adjuvant treatment protocols

Research explores histologic subtypes, biomarker‑driven approaches, and combination regimens.

Interstitial Lung Disease & Fibrosis

Investigator addresses progressive lung disorders such as idiopathic pulmonary fibrosis and broader interstitial lung disease entities.

  • Antifibrotic combination strategies
  • Evaluation of lung function trajectories
  • Impact of inflammatory components on disease progression

Efforts include assessment of forced vital capacity changes and quality‑of‑life outcomes.

Autoimmune Vasculitis & Systemic Rheumatology

Investigator is engaged in the study of systemic immune disorders, including ANCA‑associated vasculitis and systemic sclerosis with pulmonary involvement.

  • Renal protection in vasculitic disease
  • Maintenance immunomodulation
  • Skin fibrosis reduction strategies

Research emphasizes organ‑specific outcomes and steroid‑sparing approaches.

Severe Asthma & Respiratory Immunology

Investigator focuses on chronic airway inflammation, particularly well‑controlled severe allergic asthma.

  • Biologic therapy optimization
  • Withdrawal and tapering protocols
  • Long‑term exacerbation monitoring

Studies aim to balance disease control with reduction of medication burden.

Oncology Beyond the Lung

Investigator extends expertise to extra‑pulmonary malignancies such as breast cancer, colorectal cancer and muscle‑invasive bladder cancer.

  • Targeted endocrine and HER2‑directed therapies
  • Combination regimens with chemotherapy
  • Biomarker‑guided treatment selection

Work includes evaluation of recurrence risk and adjuvant therapeutic impact.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.